Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

585
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
585
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

4.5K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.5K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

172
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
172
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

249
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
249
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

6.0K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.0K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

75
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
75

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digitization of Historical Data from Somalia's Last Smallpox Outbreaks 1976-1977.

Scientific data·2026
Same author

Progression of multiple long-term conditions (multimorbidity) in England: a population-based descriptive study of 49·6 million adults.

The Lancet. Public health·2026
Same author

Professor Ian Hall's contribution to the Discussion of 'Some statistical aspects of the COVID-19 response' by Wood et al.

Journal of the Royal Statistical Society. Series A, (Statistics in Society)·2026
Same author

Association between the English National Health Service Diabetes Prevention Programme and incident multiple long-term conditions.

Nature medicine·2025
Same author

A within-host birth-death and time-dose-response model for Legionnaires' disease.

Royal Society open science·2025
Same author

Time-varying reproduction number estimation: fusing compartmental models with generalized additive models.

Journal of the Royal Society, Interface·2025

Related Experiment Video

Updated: Dec 8, 2025

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

17.0K

Dose-Response Modeling: Extrapolating From Experimental Data to Real-World Populations.

Adrian Pratt1, Emma Bennett1, Joseph Gillard2

  • 1Emergency Response Department, Public Health England, Porton Down, UK.

Risk Analysis : an Official Publication of the Society for Risk Analysis
|September 23, 2020
PubMed
Summary

This study enhances dose-response models for biological agents by incorporating real-world variability, preventing overestimation of infection risks from anthrax and plague.

Keywords:
Competing-risks frameworkdose-response modelingquantitative microbial risk assessment

More Related Videos

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

13.4K
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.3K

Related Experiment Videos

Last Updated: Dec 8, 2025

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

17.0K
Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

13.4K
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.3K

Area of Science:

  • Biostatistics
  • Infectious Disease Modeling
  • Risk Assessment

Background:

  • Traditional dose-response models often rely solely on controlled laboratory data.
  • Real-world scenarios introduce variability (e.g., dose dispersion, deposition) not typically accounted for.
  • This limitation can lead to inaccurate predictions of infection risk.

Purpose of the Study:

  • To develop a probabilistic framework extending existing dose-response models.
  • To incorporate variations in within-host parameters and exposure dynamics.
  • To improve the accuracy of infection risk predictions for biological agents.

Main Methods:

  • Extended Brookmeyer's competing-risks dose-response model.
  • Developed a probabilistic framework to account for dose-dispersion and dose-deposition.
  • Utilized data from inhalational anthrax, plague, and tularemia experiments.

Main Results:

  • The enhanced model accounts for variability in key exposure and within-host parameters.
  • Demonstrated potential overestimation of infection numbers by models using only experimental data.
  • Illustrated the impact of real-world factors on dose-response predictions.

Conclusions:

  • Probabilistic dose-response modeling is crucial for accurate risk assessment of biological agents.
  • Accounting for real-world variability is essential to avoid overestimating infection risks.
  • The developed framework offers a more realistic approach to modeling infectious disease exposure.